Second International Urology Cancer Summit
27.09.24 – Portsmouth, UK
Time zone is BST (British Summer Time)
09:00
Welcome by Chairs
Giuseppe Luigi Banna (UK) & Ravindran Kanesvaran (Singapore)
Urothelial Cancer
09:05 – 09:25
The role of immunotherapy in the evolving treatment landscape of UC
Simon Crabb, Southampton, UK
09:25- 09:45
Shall we treat mUTUC in a different way
Patrizia Giannatempo, Milan, Italy
09:45 – 10:05
Contemporary options in non-metastatic bladder cancer
Param Mariappan, Edinburgh, UK
10:05 – 10:25
Who is suitable for bladder sparing treatment in 2024?
Ananya Choudhury, Manchester, UK
Diagnostics and Biomarkers
10:25 – 10:45
Staging by imaging: Where we stand in prostate cancer
Akash Maniam, Portsmouth, UK
10:45 – 11:05
Liquid vs tumour biopsy in urological tumours
Christian Rolfo, New York, US
11:05 – 11:20
Coffee Break – (ePoster Session)
Prostate Cancer
11:20 – 11:40
Treatment escalation and de-escalation in mHSPC
Pasquale Rescigno, Newcastle, UK
11:40 – 12:00
How first- and second-line treatment of mCRPC is evolving
Neeraj Agarwal, Salt Lake City, US
12:00 – 12:20
Patient-friendly fractionation for localised disease
Alison Tree, London, UK
12:20 – 15:00
Industry Symposia – View List
(including lunch break)
13:20 – 14:15
Lunch – (ePoster Session)
15:00 – 15:20
Poster Award
Renal
15:20 – 15:40
Intensification and de-intensification in the treatment of mRCC
Monty Pal, Los Angeles, US
15:40 – 16:00
Updating treatment sequencing for mRCC
Naveen Vasudev, Leeds, UK
16:00 – 16:20
Clinical case quiz
Yüksel Ürün, Ankara, Turkey
16:20 – 16:35
Coffee break (ePoster Session)
Real-world
16:35 – 16:55
Inequity as a barrier to access
Ravindran Kanesvaran, Singapore
16:55 – 17:15
The relevance of QoL outcomes in clinical trials and the real world
Laura Marandino, London, UK